ImmuCell Corporation IUL.F Stock
ImmuCell Corporation Price Chart
ImmuCell Corporation IUL.F Financial and Trading Overview
| ImmuCell Corporation stock price | 4.36 EUR |
| Previous Close | 5.05 EUR |
| Open | 4.98 EUR |
| Bid | 4.96 EUR x 300000 |
| Ask | 5.1 EUR x 300000 |
| Day's Range | 4.98 - 4.98 EUR |
| 52 Week Range | 4.22 - 8.9 EUR |
| Volume | 100 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 38.63M EUR |
| Beta (5Y Monthly) | 0.665492 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.7 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IUL.F Valuation Measures
| Enterprise Value | 49.64M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.4123676 |
| Price/Book (mrq) | 1.3700137 |
| Enterprise Value/Revenue | 3.099 |
| Enterprise Value/EBITDA | -20.065 |
Trading Information
ImmuCell Corporation Stock Price History
| Beta (5Y Monthly) | 0.665492 |
| 52-Week Change | -32.45% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.9 EUR |
| 52 Week Low | 4.22 EUR |
| 50-Day Moving Average | 4.56 EUR |
| 200-Day Moving Average | 6.23 EUR |
IUL.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 7.75M |
| Float | 5.53M |
| Short Ratio | N/A |
| % Held by Insiders | 28.65% |
| % Held by Institutions | 13.47% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -33.23% |
| Operating Margin (ttm) | -31.19% |
| Gross Margin | 31.06% |
| EBITDA Margin | -15.44% |
Management Effectiveness
| Return on Assets (ttm) | -6.95% |
| Return on Equity (ttm) | -17.29% |
Income Statement
| Revenue (ttm) | 16.01M EUR |
| Revenue Per Share (ttm) | 2.07 EUR |
| Quarterly Revenue Growth (yoy) | -42.60% |
| Gross Profit (ttm) | 7.65B EUR |
| EBITDA | -2473721 EUR |
| Net Income Avi to Common (ttm) | -5322145 EUR |
| Diluted EPS (ttm) | -0.67 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.1M EUR |
| Total Cash Per Share (mrq) | 0.4 EUR |
| Total Debt (mrq) | 13.22M EUR |
| Total Debt/Equity (mrq) | 46.95 EUR |
| Current Ratio (mrq) | 3.191 |
| Book Value Per Share (mrq) | 3.635 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4944391 EUR |
| Levered Free Cash Flow (ttm) | -6585390 EUR |
Profile of ImmuCell Corporation
| Country | Germany |
| State | ME |
| City | Portland |
| Address | 56 Evergreen Drive |
| ZIP | 04103 |
| Phone | 207 878 2770 |
| Website | https://immucell.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 67 |
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
Q&A For ImmuCell Corporation Stock
What is a current IUL.F stock price?
ImmuCell Corporation IUL.F stock price today per share is 4.36 EUR.
How to purchase ImmuCell Corporation stock?
You can buy IUL.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ImmuCell Corporation?
The stock symbol or ticker of ImmuCell Corporation is IUL.F.
Which industry does the ImmuCell Corporation company belong to?
The ImmuCell Corporation industry is Biotechnology.
How many shares does ImmuCell Corporation have in circulation?
The max supply of ImmuCell Corporation shares is 7.82M.
What is ImmuCell Corporation Price to Earnings Ratio (PE Ratio)?
ImmuCell Corporation PE Ratio is now.
What was ImmuCell Corporation earnings per share over the trailing 12 months (TTM)?
ImmuCell Corporation EPS is -0.7 EUR over the trailing 12 months.
Which sector does the ImmuCell Corporation company belong to?
The ImmuCell Corporation sector is Healthcare.